NeuroOne (NMTC) Form 8-K Summary

Item 3.01: Listing Compliance Extension

NeuroOne Medical Technologies Corporation received notification from Nasdaq granting a 180-day extension to regain compliance with the Minimum Bid Price Requirement ($1.00 per share).

• Extension Deadline: May 4, 2026.
• The Company failed to meet the prior compliance deadline (November 3, 2025).
• Current listing status on the Nasdaq Capital Market remains fully effective.

Failure to cure the deficiency by the new deadline subjects the Common Stock to delisting, requiring a potential appeal to